These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21823548)

  • 1. Considerations for the upcoming FDA REMS proposal.
    Peppin JF; Coleman JJ; Kirsh KL
    J Opioid Manag; 2011; 7(3):173-6. PubMed ID: 21823548
    [No Abstract]   [Full Text] [Related]  

  • 2. Narcotic pain relievers: are you using them correctly?
    Johns Hopkins Med Lett Health After 50; 2012 Nov; 24(10):1-2. PubMed ID: 23362527
    [No Abstract]   [Full Text] [Related]  

  • 3. Access to opioids: a balance of harms.
    The Lancet Oncology
    Lancet Oncol; 2017 Oct; 18(10):1285. PubMed ID: 28971809
    [No Abstract]   [Full Text] [Related]  

  • 4. Oncologists want FDA to rethink REMS.
    Goozner M
    J Natl Cancer Inst; 2010 Dec; 102(23):1748-9, 1751. PubMed ID: 21088276
    [No Abstract]   [Full Text] [Related]  

  • 5. Evolution of opioid risk management and review of the classwide REMS for extended-release/long-acting opioids.
    Stanos S
    Phys Sportsmed; 2012 Nov; 40(4):12-20. PubMed ID: 23306411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Evaluation and Mitigation Strategies (REMS) for extended-release and long-acting opioid analgesics: considerations for palliative care practice.
    Gudin J
    J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):136-43. PubMed ID: 22764852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-release/long-acting opioid REMS may fill the need for prescribers' appropriate use education.
    Nicholson SC; Evanyo K; Salinas GD; Roepke N; Burton BS; Susalka D
    J Opioid Manag; 2012; 8(4):212-6. PubMed ID: 22941848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain treatment agreements.
    Rowe W
    Am J Bioeth; 2010 Nov; 10(11):3-4. PubMed ID: 21104544
    [No Abstract]   [Full Text] [Related]  

  • 9. Curbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS).
    Nelson LS; Perrone J
    JAMA; 2012 Aug; 308(5):457-8. PubMed ID: 22851109
    [No Abstract]   [Full Text] [Related]  

  • 10. Opioid risk management: understanding FDA mandated risk evaluation and mitigation strategies (REMS).
    Sloan PA
    J Opioid Manag; 2009; 5(3):131-3. PubMed ID: 19662921
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA opioid safety plan promotes patient, physician education to prevent abuse.
    Kuehn BM
    JAMA; 2010 Aug; 304(8):845. PubMed ID: 20736462
    [No Abstract]   [Full Text] [Related]  

  • 12. Are opioid risk evaluation and mitigation strategies (REMS) interrupting your sleep?
    Craig DS
    J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):134-5. PubMed ID: 22764851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA remodels REMS for opioid medications.
    Stone A
    ONS Connect; 2012 Sep; 27(9):18. PubMed ID: 23008909
    [No Abstract]   [Full Text] [Related]  

  • 14. Manufacturers argue against mandatory training for opioid prescribers.
    Traynor K
    Am J Health Syst Pharm; 2010 Jan; 67(2):96. PubMed ID: 20065261
    [No Abstract]   [Full Text] [Related]  

  • 15. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA to tighten labeling on long acting opioids.
    McCarthy M
    BMJ; 2013 Sep; 347():f5581. PubMed ID: 24030791
    [No Abstract]   [Full Text] [Related]  

  • 17. Issues and critiques of the forthcoming risk evaluation and mitigation strategy (REMS) for opioids in pain management.
    Peppin JF; Coleman JJ; Kirsh KL
    Issues Law Med; 2011; 27(2):91-119. PubMed ID: 22372206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Painkillers fuel growth in drug addiction. Opioid overdoses now kill more people than cocaine or heroin.
    Harv Ment Health Lett; 2011 Jan; 27(7):4-5. PubMed ID: 21322902
    [No Abstract]   [Full Text] [Related]  

  • 19. The FDA's Approach to the Prescription Opioid Problem.
    Woodcock J; Throckmorton DC
    Clin Pharmacol Ther; 2018 Jun; 103(6):954-955. PubMed ID: 29570773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why medical students need addictions training.
    Cantone RE
    Med Teach; 2018 Apr; 40(4):421-422. PubMed ID: 29094624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.